Novo Nordisk to cut Wegovy
Photo: Johan Nilsson/ TT

Novo Nordisk to cut Wegovy and Ozempic prices in the US by up to 50 percent starting January 2027

Danish pharmaceutical giant Novo Nordisk has announced that it will reduce the prices of Wegovy and Ozempic in the US by up to 50 percent starting in January 2027, the Wall Street Journal reports.

Advertisement

The announcement further intensifies the price war that the company is currently in with American competitor Eli Lilly over its weight-loss drugs.

On Monday, a study was also presented in which Eli Lilly showed better results than Novo Nordisk, causing the Danish company's stock to fall sharply.

AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All